Integrated DNA Technologies
@idtdna.bsky.social
Our vision of enabling researchers to rapidly move from the lab to life-changing advances reflects our commitment to a healthier, brighter future for all. 🧬
idtdna.com
Privacy Notice: https://idtb.io/privacy
idtdna.com
Privacy Notice: https://idtb.io/privacy
Looking forward to a totally tubular time at #AGBT26!🤙
Meet with IDT trusted experts and learn how our NGS portfolio is powering discoveries across cancer research with unmatched customization, streamlined workflows, and innovations that scale complex applications with confidence.
🔗 idtb.io/1y5me0
Meet with IDT trusted experts and learn how our NGS portfolio is powering discoveries across cancer research with unmatched customization, streamlined workflows, and innovations that scale complex applications with confidence.
🔗 idtb.io/1y5me0
February 5, 2026 at 4:40 PM
Looking forward to a totally tubular time at #AGBT26!🤙
Meet with IDT trusted experts and learn how our NGS portfolio is powering discoveries across cancer research with unmatched customization, streamlined workflows, and innovations that scale complex applications with confidence.
🔗 idtb.io/1y5me0
Meet with IDT trusted experts and learn how our NGS portfolio is powering discoveries across cancer research with unmatched customization, streamlined workflows, and innovations that scale complex applications with confidence.
🔗 idtb.io/1y5me0
What incredible news to welcome on #WorldCancerDay. We're delighted to see that Congress has passed legislation establishing a pathway for Medicare coverage of multi‑cancer early detection tests—a breakthrough that could expand access to cancer screenings and save countless lives: lnkd.in/gyPiznjX
February 4, 2026 at 1:08 PM
What incredible news to welcome on #WorldCancerDay. We're delighted to see that Congress has passed legislation establishing a pathway for Medicare coverage of multi‑cancer early detection tests—a breakthrough that could expand access to cancer screenings and save countless lives: lnkd.in/gyPiznjX
When you're congratulated for exciting new data, which now means you need to do more experiments. 💀
February 2, 2026 at 10:19 PM
When you're congratulated for exciting new data, which now means you need to do more experiments. 💀
Looking to accelerate your #infectiousdiseaseresearch? We offer both ready-to-use and custom solutions—from our PrimeTime™ Pathogen Research Panels to our custom amplicon NGS panels, we’re here to propel your research with flexibility, speed, and scalability. Start here: idtb.io/o9tw8t
February 2, 2026 at 4:15 PM
Looking to accelerate your #infectiousdiseaseresearch? We offer both ready-to-use and custom solutions—from our PrimeTime™ Pathogen Research Panels to our custom amplicon NGS panels, we’re here to propel your research with flexibility, speed, and scalability. Start here: idtb.io/o9tw8t
IDT President Ajay Gannerkote discussed the importance of #MRDmonitoring and #MCED to the future of #cancercare on a panel at the annual #HLTHconference—take a look below. 👇
#cancerresearch #oncologyresearch #personalizedmedicine #precisionmedicine #HLTHevents
#cancerresearch #oncologyresearch #personalizedmedicine #precisionmedicine #HLTHevents
January 30, 2026 at 1:23 PM
IDT President Ajay Gannerkote discussed the importance of #MRDmonitoring and #MCED to the future of #cancercare on a panel at the annual #HLTHconference—take a look below. 👇
#cancerresearch #oncologyresearch #personalizedmedicine #precisionmedicine #HLTHevents
#cancerresearch #oncologyresearch #personalizedmedicine #precisionmedicine #HLTHevents
We’re having a blast at Festival of Genomics and Biodata in London! 🎡
Want to learn more about how our NGS tools can streamline your workflows and help you achieve accurate, reliable results? Join us at booth #143B—we’re excited to chat with you! 👋
#FOG2026 #FOG26 #NGS #nextgenerationsequencing
Want to learn more about how our NGS tools can streamline your workflows and help you achieve accurate, reliable results? Join us at booth #143B—we’re excited to chat with you! 👋
#FOG2026 #FOG26 #NGS #nextgenerationsequencing
January 28, 2026 at 1:06 PM
We’re having a blast at Festival of Genomics and Biodata in London! 🎡
Want to learn more about how our NGS tools can streamline your workflows and help you achieve accurate, reliable results? Join us at booth #143B—we’re excited to chat with you! 👋
#FOG2026 #FOG26 #NGS #nextgenerationsequencing
Want to learn more about how our NGS tools can streamline your workflows and help you achieve accurate, reliable results? Join us at booth #143B—we’re excited to chat with you! 👋
#FOG2026 #FOG26 #NGS #nextgenerationsequencing
Imagine a world where #cancercare is so personalized that we can treat it on a cellular level. That’s where we’re heading with the power of MRD monitoring and MCED. Our experts and NGS solutions are accelerating the research behind this progress—learn more here: lnkd.in/eYe4cAmX
Driving precision oncology discovery: How IDT powers MRD assessment and multi-cancer detection research
Cancer remains one of the most challenging health concerns of our time. In 2025, more than two million new cancer cases are expected to be diagnosed in the U.
lnkd.in
January 27, 2026 at 3:18 PM
Imagine a world where #cancercare is so personalized that we can treat it on a cellular level. That’s where we’re heading with the power of MRD monitoring and MCED. Our experts and NGS solutions are accelerating the research behind this progress—learn more here: lnkd.in/eYe4cAmX
IDT President Ajay Gannerkote writes about how AI is accelerating the future of synbio—from designing gene-editing components with precision to predicting protein functions. However, as AI-enabled tools advance, so do the biosecurity challenges. Read more: www.ddw-online.com/how-ai-is-tr...
How AI is transforming gene synthesis and genome engineering - Drug Discovery World (DDW)
Ajay Gannerkote, President, Integrated DNA Technologies examines how AI is helping to advance the drug discovery landscape. In the past decade, few fields in biotechnology have evolved as dramatically...
www.ddw-online.com
January 26, 2026 at 5:34 PM
IDT President Ajay Gannerkote writes about how AI is accelerating the future of synbio—from designing gene-editing components with precision to predicting protein functions. However, as AI-enabled tools advance, so do the biosecurity challenges. Read more: www.ddw-online.com/how-ai-is-tr...
NEW eBOOK DROP! 📖
Our new expert guide will help you master FDA and EMA requirements, streamline your development process, and ensure compliant, ethical #CRISPRtherapeutics. Don’t miss your chance to get this free resource! Download here: idtb.io/fl3hkq
#regulatory #CRISPR #CRISPRtherapies
Our new expert guide will help you master FDA and EMA requirements, streamline your development process, and ensure compliant, ethical #CRISPRtherapeutics. Don’t miss your chance to get this free resource! Download here: idtb.io/fl3hkq
#regulatory #CRISPR #CRISPRtherapies
January 22, 2026 at 6:57 PM
NEW eBOOK DROP! 📖
Our new expert guide will help you master FDA and EMA requirements, streamline your development process, and ensure compliant, ethical #CRISPRtherapeutics. Don’t miss your chance to get this free resource! Download here: idtb.io/fl3hkq
#regulatory #CRISPR #CRISPRtherapies
Our new expert guide will help you master FDA and EMA requirements, streamline your development process, and ensure compliant, ethical #CRISPRtherapeutics. Don’t miss your chance to get this free resource! Download here: idtb.io/fl3hkq
#regulatory #CRISPR #CRISPRtherapies
ICYMI: We’re partnering with @ansabio.bsky.social to provide customers with access to long, #complexDNA, ranging from 100 bp to 50 kb! Take a look at how this collaboration has delivered value to Manos Papadakis, Senior Research Scientist, @dsmfirmenich.bsky.social. 👇
Read more: idtb.io/c2tiva
Read more: idtb.io/c2tiva
January 21, 2026 at 3:03 PM
ICYMI: We’re partnering with @ansabio.bsky.social to provide customers with access to long, #complexDNA, ranging from 100 bp to 50 kb! Take a look at how this collaboration has delivered value to Manos Papadakis, Senior Research Scientist, @dsmfirmenich.bsky.social. 👇
Read more: idtb.io/c2tiva
Read more: idtb.io/c2tiva
We’re delighted to return to Festival of Genomics and Biodata 2026! Join us at booth #143B to learn how our #NGS tools can streamline your workflows and help you achieve accurate, reliable results. Learn more here: hubs.la/Q03WbxXV0
#FOG2026 #FestivalofGenomics #NGStools
#FOG2026 #FestivalofGenomics #NGStools
January 21, 2026 at 1:16 PM
We’re delighted to return to Festival of Genomics and Biodata 2026! Join us at booth #143B to learn how our #NGS tools can streamline your workflows and help you achieve accurate, reliable results. Learn more here: hubs.la/Q03WbxXV0
#FOG2026 #FestivalofGenomics #NGStools
#FOG2026 #FestivalofGenomics #NGStools
ICYMI: We’re not just expanding our footprint in Sunnyvale—we’re welcoming back a visionary leader. As part of this strategic move, Steven Henck returns to IDT as Chief Technology Officer! 👏🧬
Learn more: idtb.io/nkq0c5
Learn more: idtb.io/nkq0c5
January 20, 2026 at 5:35 PM
ICYMI: We’re not just expanding our footprint in Sunnyvale—we’re welcoming back a visionary leader. As part of this strategic move, Steven Henck returns to IDT as Chief Technology Officer! 👏🧬
Learn more: idtb.io/nkq0c5
Learn more: idtb.io/nkq0c5
#Cancercare is evolving, and #precisiononcology is leading the way. Learn how #MRD assessment and #MCED are transforming treatment strategies and how IDT’s advanced #NGSsolutions are powering the research behind this progress: idtb.io/xtkf2o
#cancerresearch #oncologyresearch
#cancerresearch #oncologyresearch
January 16, 2026 at 4:26 PM
#Cancercare is evolving, and #precisiononcology is leading the way. Learn how #MRD assessment and #MCED are transforming treatment strategies and how IDT’s advanced #NGSsolutions are powering the research behind this progress: idtb.io/xtkf2o
#cancerresearch #oncologyresearch
#cancerresearch #oncologyresearch
It was a full house last night at our JPM event with Mithrl! Our panel explored some of the most pressing questions around #AI in biology. IDT's Steven Henck reminded us that AI won’t replace scientists—but scientists using AI will lead the way. “AI is not just a tool. It’s becoming a collaborator.”
January 15, 2026 at 4:20 PM
It was a full house last night at our JPM event with Mithrl! Our panel explored some of the most pressing questions around #AI in biology. IDT's Steven Henck reminded us that AI won’t replace scientists—but scientists using AI will lead the way. “AI is not just a tool. It’s becoming a collaborator.”
New partnership announcement! 🤝
We’re proud to collaborate with @ansabio.bsky.social to provide our customers with access to long, complex #clonalDNA ranging from 100 bp to 50 kb. Read more here: idtb.io/xfs37g
#SyntheticBiology #DNASynthesis #synbio #lifesciencesnews
We’re proud to collaborate with @ansabio.bsky.social to provide our customers with access to long, complex #clonalDNA ranging from 100 bp to 50 kb. Read more here: idtb.io/xfs37g
#SyntheticBiology #DNASynthesis #synbio #lifesciencesnews
January 14, 2026 at 1:29 PM
New partnership announcement! 🤝
We’re proud to collaborate with @ansabio.bsky.social to provide our customers with access to long, complex #clonalDNA ranging from 100 bp to 50 kb. Read more here: idtb.io/xfs37g
#SyntheticBiology #DNASynthesis #synbio #lifesciencesnews
We’re proud to collaborate with @ansabio.bsky.social to provide our customers with access to long, complex #clonalDNA ranging from 100 bp to 50 kb. Read more here: idtb.io/xfs37g
#SyntheticBiology #DNASynthesis #synbio #lifesciencesnews
Big news! 📍 We’re relocating our Redwood City site to Sunnyvale, California! Our new facility will feature state-of-the-art lab and office space designed to foster greater innovation, enhance R&D initiatives, and deepen collaboration opportunities with partners.
🔗Read more: idtb.io/nkq0c5
🔗Read more: idtb.io/nkq0c5
January 13, 2026 at 2:16 PM
Big news! 📍 We’re relocating our Redwood City site to Sunnyvale, California! Our new facility will feature state-of-the-art lab and office space designed to foster greater innovation, enhance R&D initiatives, and deepen collaboration opportunities with partners.
🔗Read more: idtb.io/nkq0c5
🔗Read more: idtb.io/nkq0c5
Let us power your infectious disease research! 💪
With a legacy of customization, agility and global expertise, you can trust in us to ensure your #qPCR and #NGS workflows are ready-built for current and emerging global health threats.
Propel your research forward: idtb.io/o9tw8t
With a legacy of customization, agility and global expertise, you can trust in us to ensure your #qPCR and #NGS workflows are ready-built for current and emerging global health threats.
Propel your research forward: idtb.io/o9tw8t
January 9, 2026 at 4:53 PM
Let us power your infectious disease research! 💪
With a legacy of customization, agility and global expertise, you can trust in us to ensure your #qPCR and #NGS workflows are ready-built for current and emerging global health threats.
Propel your research forward: idtb.io/o9tw8t
With a legacy of customization, agility and global expertise, you can trust in us to ensure your #qPCR and #NGS workflows are ready-built for current and emerging global health threats.
Propel your research forward: idtb.io/o9tw8t
Cancer care is evolving, and #precisiononcology is leading the way. Learn how #MRD monitoring and #MCED are transforming treatment strategies and how IDT is delivering advanced #NGSsolutions that are precision-engineered to power the research behind this progress.
🔗Read our blog: idtb.io/yifp65
🔗Read our blog: idtb.io/yifp65
MRD and MCED NGS Solutions for Precision Oncology | IDT
Discover how IDT NGS solutions enable MRD monitoring and MCED research to advance precision oncology and earlier cancer insights.
idtb.io
January 7, 2026 at 2:27 PM
Cancer care is evolving, and #precisiononcology is leading the way. Learn how #MRD monitoring and #MCED are transforming treatment strategies and how IDT is delivering advanced #NGSsolutions that are precision-engineered to power the research behind this progress.
🔗Read our blog: idtb.io/yifp65
🔗Read our blog: idtb.io/yifp65
IDT’s Alt-R™ HDR Enhancer Protein🌟
Boost HDR efficiency without compromising genomic integrity and cell viability. This first-to-market protein enables precise editing of the gene—compatible with a variety of cell types (such as iPSC & HSBCs), nucleases, and donor templates: https://idtb.io/fov3yc
Boost HDR efficiency without compromising genomic integrity and cell viability. This first-to-market protein enables precise editing of the gene—compatible with a variety of cell types (such as iPSC & HSBCs), nucleases, and donor templates: https://idtb.io/fov3yc
January 6, 2026 at 4:12 PM
IDT’s Alt-R™ HDR Enhancer Protein🌟
Boost HDR efficiency without compromising genomic integrity and cell viability. This first-to-market protein enables precise editing of the gene—compatible with a variety of cell types (such as iPSC & HSBCs), nucleases, and donor templates: https://idtb.io/fov3yc
Boost HDR efficiency without compromising genomic integrity and cell viability. This first-to-market protein enables precise editing of the gene—compatible with a variety of cell types (such as iPSC & HSBCs), nucleases, and donor templates: https://idtb.io/fov3yc
⏰It’s almost time for our Bay Area happy hour!
Join us for an exclusive panel discussion on the future of biopharma and networking opportunities with IDT experts and leaders shaping the future of science.
🔗Claim your spot: luma.com/4nka1da9
#JPM26 #JPM2026
Join us for an exclusive panel discussion on the future of biopharma and networking opportunities with IDT experts and leaders shaping the future of science.
🔗Claim your spot: luma.com/4nka1da9
#JPM26 #JPM2026
January 6, 2026 at 3:23 PM
⏰It’s almost time for our Bay Area happy hour!
Join us for an exclusive panel discussion on the future of biopharma and networking opportunities with IDT experts and leaders shaping the future of science.
🔗Claim your spot: luma.com/4nka1da9
#JPM26 #JPM2026
Join us for an exclusive panel discussion on the future of biopharma and networking opportunities with IDT experts and leaders shaping the future of science.
🔗Claim your spot: luma.com/4nka1da9
#JPM26 #JPM2026
Multi-cancer early detection (MCED) and minimal residual disease (MRD) monitoring promise to detect cancer earlier, monitor treatment effectiveness more accurately, and ultimately improve patient outcomes. ✅
Read more from IDT President Ajay Gannerkote in GenomeWeb here: https://bit.ly/4b0IDtX
Read more from IDT President Ajay Gannerkote in GenomeWeb here: https://bit.ly/4b0IDtX
January 5, 2026 at 4:49 PM
Multi-cancer early detection (MCED) and minimal residual disease (MRD) monitoring promise to detect cancer earlier, monitor treatment effectiveness more accurately, and ultimately improve patient outcomes. ✅
Read more from IDT President Ajay Gannerkote in GenomeWeb here: https://bit.ly/4b0IDtX
Read more from IDT President Ajay Gannerkote in GenomeWeb here: https://bit.ly/4b0IDtX
Seamlessly validate your hits with Alt-R™ CRISPR-Cas9 Libraries! Our platform supports:
✔Custom plate layouts for adoption into automation workflows
✔A new tool that designs your library in minutes
✔Predesigned gene families
✔Integrated on- and off-target analysis tools
https://idtb.io/3bg8c0
✔Custom plate layouts for adoption into automation workflows
✔A new tool that designs your library in minutes
✔Predesigned gene families
✔Integrated on- and off-target analysis tools
https://idtb.io/3bg8c0
January 2, 2026 at 3:36 PM
Seamlessly validate your hits with Alt-R™ CRISPR-Cas9 Libraries! Our platform supports:
✔Custom plate layouts for adoption into automation workflows
✔A new tool that designs your library in minutes
✔Predesigned gene families
✔Integrated on- and off-target analysis tools
https://idtb.io/3bg8c0
✔Custom plate layouts for adoption into automation workflows
✔A new tool that designs your library in minutes
✔Predesigned gene families
✔Integrated on- and off-target analysis tools
https://idtb.io/3bg8c0
Decoded+™ is your go-to blog for the latest in genomics news, expert insights and updates from IDT.
Whether you’re seeking answers to tough research challenges or just want to learn something new, we’re here with content you can trust. 🧬🤝
Visit here: https://idtb.io/w8xr4f
Whether you’re seeking answers to tough research challenges or just want to learn something new, we’re here with content you can trust. 🧬🤝
Visit here: https://idtb.io/w8xr4f
December 31, 2025 at 4:01 PM
Decoded+™ is your go-to blog for the latest in genomics news, expert insights and updates from IDT.
Whether you’re seeking answers to tough research challenges or just want to learn something new, we’re here with content you can trust. 🧬🤝
Visit here: https://idtb.io/w8xr4f
Whether you’re seeking answers to tough research challenges or just want to learn something new, we’re here with content you can trust. 🧬🤝
Visit here: https://idtb.io/w8xr4f
Not all gRNAs are created equally. Our rigorous QC methods show our #gRNAs are about 10% purer than the competition. Misleading data can skew your research—see the numbers for yourself and be confident when editing in sensitive applications: https://idtb.io/kx8kum
#CRISPR #gRNA #guideRNA
#CRISPR #gRNA #guideRNA
December 30, 2025 at 4:18 PM
Not all gRNAs are created equally. Our rigorous QC methods show our #gRNAs are about 10% purer than the competition. Misleading data can skew your research—see the numbers for yourself and be confident when editing in sensitive applications: https://idtb.io/kx8kum
#CRISPR #gRNA #guideRNA
#CRISPR #gRNA #guideRNA
🔊 Tune in to The Beat podcast with Ajay Gannerkote. Learn how precision oncology is leading cancer care, how breakthroughs in #MRDassessment and #MCED are transforming diagnosis and treatment, and how IDT’s #NGS solutions are powering the research behind this progress: https://bit.ly/44yJYV1
December 29, 2025 at 5:14 PM
🔊 Tune in to The Beat podcast with Ajay Gannerkote. Learn how precision oncology is leading cancer care, how breakthroughs in #MRDassessment and #MCED are transforming diagnosis and treatment, and how IDT’s #NGS solutions are powering the research behind this progress: https://bit.ly/44yJYV1